High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer

Respiration. 1994;61(3):167-8. doi: 10.1159/000196330.


Two patients presented with intraluminal T1N0 squamous cell lung cancer. Poor lung function precluded surgical resection and/or external radiotherapy. They were treated up to 3 times with high-dose rate brachytherapy (10 Gy at 1 cm each session) with curative intent. Follow-up has been 54 and 25 months. Brachytherapy is an effective and well-tolerated bronchoscopic treatment alternative with a curative potential in patients with small T1N0 intraluminal lung cancer.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Brachytherapy*
  • Carcinoma, Squamous Cell / radiotherapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / radiotherapy*
  • Male
  • Middle Aged
  • Radiotherapy Dosage